Clinical trials
Phase 3 Gastrointestinal Stromal Tumors trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 9 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Deciphera Pharmaceuticals, LLC | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| National Cancer Institute (NCI) | 3 |
| AB Science | 2 |
| Asan Medical Center | 2 |
| GlaxoSmithKline | 2 |
| Pfizer | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Stromal Tumors | 36 |
| Neoplasm Metastasis | 3 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Renal Cell | 2 |
| Gastrointestinal Neoplasms | 2 |
| Neoplasms | 2 |
| Sarcoma | 2 |
| Adrenocortical Carcinoma | 1 |
| Anus Neoplasms | 1 |
| Appendiceal Neoplasms | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.